clofilium has been researched along with Coronary Disease in 2 studies
clofilium: RN given refers to parent cpd; structure
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gough, WB | 1 |
el-Sherif, N | 1 |
Kowey, PR | 1 |
Friehling, TD | 1 |
O'Connor, KM | 1 |
Wetstein, L | 1 |
Kelliher, GJ | 1 |
2 other studies available for clofilium and Coronary Disease
Article | Year |
---|---|
The differential response of normal and ischaemic Purkinje fibres to clofilium, d-sotalol and bretylium.
Topics: Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Coronary Disease; Dogs; Heart Conduction Syste | 1989 |
The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Cats; Coro | 1985 |